Given that previous studies demonstrated that HVEM-Fc does not alter PD-L1 protein expression, we investigated the potential synergistic effects of combining HVEM-Fc with a PD-1 inhibitor in two distinct mouse lung cancer models. Here, CD274 is linked to lung cancer.